Infectious disease research
Infectious disease research is a key service area for Oxford Outcomes. We are able to provide a complementary package of outcomes research services geared specifically to infectious disease research including: transmission modeling, disease Epidemiology, systematic review, patient and clinician reported outcomes, health technology assessment.
Oxford Outcomes is a market leader in infectious disease transmission modeling, and has integrated this into economic models to assess the effectiveness of therapeutic strategies for treating infectious disease. Our infectious disease modeling comes together with other services in Epidemiology, Health Economics and Patient Reported Outcomes to provide a full range of infectious disease services. These areas perfectly complement each other and are supported by thorough understanding of the underlying biological principles of infectious disease transmission. Our ability to integrate and innovate while maintaining rigorous standards, sets us apart from other consultancies. Our experience ensures we understand the standards required for submission of single or multiple technology assessments to NICE, the UK Joint Committee on Vaccination and Immunization (JCVI), the European Medicines Agency (EMA), the FDA or Health Canada.
Our team has experience of evaluating a range of technologies, including vaccines, antibiotics, anti-virals and anti-infectives, using a diverse variety of analyses, to explore cost-effectiveness, budget impact, pricing and the production of core value documents. While some of these techniques may be unfamiliar to clients, we are able to deliver results in an easy to use, clear and comprehensible format that addresses the objectives set by our clients.
Find our more about our team and contact them here.